Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAD51 | Q06609 | 11/20 | 1.00 |
| ▸ | BCL2A1 | Q16548 | 4/20 | 1.00 |
| ▸ | RAD1 | O60671 | 1/20 | 1.00 |
| ▸ | MAPT | P10636 | 4/20 | 0.81 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.71 |
| ▸ | LMNA | P02545 | 1/20 | 0.71 |
| ▸ | BCL2 | P10415 | 1/20 | 0.71 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.71 |
| ▸ | BID | P55957 | 1/20 | 0.71 |
| ▸ | BCL2L1 | Q07817 | 1/20 | 0.71 |
| ▸ | BCL2L2 | Q92843 | 1/20 | 0.71 |
| ▸ | PKM | P14618 | 1/20 | 0.71 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.71 |
| ▸ | TSHR | P16473 | 1/20 | 0.71 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.71 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.71 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.71 |
| ▸ | MEN1 | O00255 | 1/20 | 0.69 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.69 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.68 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15758553 | 0.89 | RAD51 (1.00) | RAD51BCL2A1RAD1MAPTALDH1A1 | |
| SCHEMBL15758239 | 0.88 | RAD51 (1.00) | RAD51BCL2A1RAD1MAPTALDH1A1 | |
| SCHEMBL15758766 | 0.88 | RAD51 (1.00) | RAD51BCL2A1RAD1MAPTALDH1A1 | |
| SCHEMBL15758684 | 0.88 | RAD51 (1.00) | RAD51BCL2A1RAD1MAPTALDH1A1 | |
| SCHEMBL13912151 | 0.87 | BCL2A1 (0.77) | RAD51BCL2A1RAD1MAPTALDH1A1 | |
| SCHEMBL15758931 | 0.86 | RAD51 (1.00) | RAD51BCL2A1RAD1MAPTALDH1A1 | |
| SCHEMBL15758185 | 0.86 | RAD51 (1.00) | RAD51BCL2A1RAD1MAPTALDH1A1 | |
| SCHEMBL13912138 | 0.86 | BCL2A1 (0.75) | RAD51BCL2A1RAD1MAPTALDH1A1 | |
| SCHEMBL13186473 | 0.84 | RAD51 (1.00) | RAD51BCL2A1RAD1MAPTALDH1A1 | |
| SCHEMBL15758820 | 0.84 | RAD51 (1.00) | RAD51BCL2A1RAD1MAPTALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2012 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122063283-A | Discontinuous reaction container arrangement reconstruction and vacancy reckoning method based on double sensors | 东方伊诺(苏州)医疗科技有限公司 | 2026-05-19 | — | — | CN | claimed |
| US-12618999-B2 | Photoelectric fusion in-situ detection device and method for thermal volatile gases and thermal evolution stages of underground oil shale | JILIN UNIVERSITY (CN) | 2026-05-05 | — | — | US | claimed |
| US-20260103103-A1 | DAY-AHEAD AND INTRA-DAY MULTI-TIME-SCALE OPTIMAL CONTROL METHOD FOR MICROGRID OF CHARGING-SWAPPING STATION | JIANGSU ELECTRIC POWER RESEARCH INSTITUTE CO, LTD. (CN) | 2026-04-16 | — | — | US | claimed |
| US-12540342-B2 | Long-chain composition, long-chain composition set, its preparation and application thereof | CHINA PETROLEUM & CHEMICAL CORPORATION (CN) | 2026-02-03 | — | — | US | claimed |
| US-12496357-B2 | Compositions and methods for treating sickle cell disease | YALE UNIVERSITY (US) | 2025-12-16 | — | — | US | claimed |
| EP-4661325-A2 | UPLINK CONTROL INFORMATION SENDING METHOD, UPLINK CONTROL INFORMATION RECEIVING METHOD, APPARATUS, AND SYSTEM | Huawei Technologies Co., Ltd. (CN) | 2025-12-10 | — | — | EP | claimed |
| US-20250345443-A1 | PHARMACEUTICAL COMPOUND AND USE THEREOF | DUALITY BIOLOGICS SUZHOU CO LTD (CN) | 2025-11-13 | — | — | US | claimed |
| US-20250320192-A1 | DEUTERIUM-ENRICHED PIPERIDINONYL-OXOISOINDOLINYL ACETAMIDES AND METHODS OF TREATING MEDICAL DISORDERS USING SAME | DEUTERX LLC (US) | 2025-10-16 | — | — | US | claimed |
| US-20250315498-A1 | METHOD AND A SYSTEM FOR COMPUTER-IMPLEMENTED PROCESSING OF DATA SAMPLES USING AN N-POINT RADIX-P-FAST FOURIER TRANSFORM, FFT | Deutsches Zentrum für Luft- und Raumfahrt e. V. (DE) | 2025-10-09 | — | — | US | claimed |
| US-12420323-B1 | Methods and devices for predicting roller gaps in non-steady-state processes | TAIYUAN UNIVERSITY OF TECHNOLOGY (CN) | 2025-09-23 | — | — | US | claimed |
| EP-3742850-B1 | UPLINK CONTROL INFORMATION SENDING METHOD, UPLINK CONTROL INFORMATION RECEIVING METHOD, APPARATUS, AND SYSTEM | HUAWEI TECH CO LTD (CN) | 2022-02-09 | — | — | EP | claimed |
| CN-109190582-B | Novel micro-expression recognition method | 河南理工大学 | 2022-02-08 | — | — | CN | claimed |
| CN-114024551-A | Data lossless compression method, system, electronic device and medium | 湖南遥昇通信技术有限公司 | 2022-02-08 | — | — | CN | claimed |
| CN-114006399-A | Optimized scheduling method for large-scale 5G base station participating in power distribution network demand response | 华北电力大学 | 2022-02-01 | — | — | CN | claimed |
| WO-2021188896-A1 | BIOMARKERS FOR SACITUZUMAB GOVITECAN THERAPY | IMMUNOMEDICS, INC. (US) | 2021-09-23 | — | — | WO | claimed |
| US-20210093730-A1 | BIOMARKERS FOR ANTIBODY-DRUG CONJUGATE MONOTHERAPY OR COMBINATION THERAPY | IMMUNOMEDICS, INC. | 2021-04-01 | — | — | US | claimed |
| US-20210085699-A1 | COMBINATION THERAPIES FOR TREATING CANCERS | THE JACKSON LABORATORY (US) | 2021-03-25 | — | — | US | claimed |
| US-10918734-B2 | Treatment of high Trop-2 expressing triple negative breast cancer (TNBC) with sacituzumab govitecan (IMMU-132) overcomes homologous recombination repair (HRR) rescue mediated by Rad51 | IMMUNOMEDICS, INC. (US) | 2021-02-16 | — | — | US | claimed |
| CN-111971048-A | Combination therapy for the treatment of cancer | 杰克逊实验室 | 2020-11-20 | — | — | CN | claimed |
| US-20180271992-A1 | TREATMENT OF HIGH TROP-2 EXPRESSING TRIPLE NEGATIVE BREAST CANCER (TNBC) WITH SACITUZUMAB GOVITECAN (IMMU-132) OVERCOMES HOMOLOGOUS RECOMBINATION REPAIR (HRR) RESCUE MEDIATED BY RAD51 | IMMUNOMEDICS, INC. | 2018-09-27 | — | — | US | claimed |